Evaluating the Feasibility, Efficacy, and Effectiveness of EMDR-DeprEnd in Reducing Depression

Evaluating the Feasibility, Efficacy, and Effectiveness of Eye movement desensitization and reprocessing Therapy Protocol for the Treatment of Depressive Disorders in Reducing Symptoms of Depression, Anxiety, and Emotion Dysregulation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251123068095N1

Enrollment

Registered

2025-12-22

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptoms of Depression.

Interventions

Intervention group: Eye Movement Desensitization and Reprocessing-Protocol for the Treatment of Depressive Disorders.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Being at least 18 years of age Obtaining an average score on the Beck Depression Inventory–II Obtaining an average score on the Beck Anxiety Inventory Obtaining an average score on the Difficulties in Emotion Regulation Scale

Exclusion criteria

Exclusion criteria: Schizophrenia Spectrum and Other Psychotic Disorders Dissociative disorders Active suicidal ideation Other contraindications for Eye Movement Desensitization and Reprocessing Therapy

Design outcomes

Primary

Measure	Time frame
Depression score on the Beck Depression Inventory–II. Timepoint: Depression score assessment before the intervention as a pre-test, assessment after the intervention as a post-test, and assessment in the follow-up phase four weeks after the intervention. Method of measurement: Beck Depression Inventory–II.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasoul Roshan Chesli

Shahed University

roshan@shahed.ac.ir+98 21 6657 3387

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026